Rigrodsky & Long, P.A. Announces Investigation Of Medicis Pharmaceutical Corporation Buyout

WILMINGTON, Del.--(BUSINESS WIRE)--Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Medicis Pharmaceutical Corporation (“Medicis” or the “Company”) (NYSE: MRX) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Valeant Pharmaceuticals International, Inc. (“Valeant”) (NYSE: VRX) in a transaction valued at approximately $2.6 billion.